Wolfgang Kruis

12.0k total citations · 2 hit papers
208 papers, 7.1k citations indexed

About

Wolfgang Kruis is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Wolfgang Kruis has authored 208 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Genetics, 78 papers in Surgery and 62 papers in Epidemiology. Recurrent topics in Wolfgang Kruis's work include Inflammatory Bowel Disease (87 papers), Microscopic Colitis (48 papers) and Diverticular Disease and Complications (33 papers). Wolfgang Kruis is often cited by papers focused on Inflammatory Bowel Disease (87 papers), Microscopic Colitis (48 papers) and Diverticular Disease and Complications (33 papers). Wolfgang Kruis collaborates with scholars based in Germany, United States and Switzerland. Wolfgang Kruis's co-authors include M. Weinzierl, P Frič, Peter Schüßler, M. Stolte, B Fixa, G Judmaier, G. Paumgartner, Ch. Thieme, Joseph Holl and Walter J. Paulus and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Wolfgang Kruis

201 papers receiving 6.7k citations

Hit Papers

Maintaining remission of ulcerative colitis with the prob... 1997 2026 2006 2016 2004 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
    2004 895 citations Wolfgang Kruis et al. Gut profile →
  2. Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
    1997 570 citations Wolfgang Kruis, M. Stolte et al. Alimentary Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Kruis Germany 42 2.9k 2.4k 2.0k 1.6k 1.4k 208 7.1k
R. D’Incà Italy 49 3.6k 1.3× 2.1k 0.8× 2.5k 1.3× 1.6k 1.0× 784 0.6× 229 7.5k
Martin Hiele Belgium 41 4.3k 1.5× 3.8k 1.6× 3.6k 1.8× 1.0k 0.6× 1.9k 1.3× 140 9.5k
Torsten Kucharzik Germany 50 3.7k 1.3× 2.5k 1.0× 2.6k 1.3× 1.8k 1.1× 911 0.6× 198 9.2k
David S. Rampton United Kingdom 51 2.7k 0.9× 2.2k 0.9× 2.0k 1.0× 1.1k 0.7× 1.0k 0.7× 128 7.8k
Hans Herfarth United States 55 4.7k 1.7× 3.0k 1.2× 4.2k 2.1× 3.1k 1.9× 1.1k 0.8× 264 12.1k
Fernando Rizzello Italy 41 4.0k 1.4× 1.9k 0.8× 2.4k 1.2× 2.7k 1.6× 1.5k 1.1× 185 7.8k
Govind Makharia India 44 2.2k 0.8× 3.7k 1.5× 3.3k 1.7× 1.1k 0.7× 3.9k 2.7× 310 8.4k
Stig Bengmark Sweden 58 1.3k 0.4× 5.2k 2.1× 2.5k 1.3× 3.6k 2.2× 809 0.6× 457 13.9k
Massimo Campieri Italy 55 6.4k 2.3× 3.2k 1.3× 4.3k 2.2× 3.8k 2.3× 2.2k 1.5× 227 12.3k
Levinus A. Dieleman Canada 50 3.7k 1.3× 2.0k 0.8× 2.1k 1.1× 3.8k 2.3× 1.1k 0.7× 180 9.4k

Countries citing papers authored by Wolfgang Kruis

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Kruis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Kruis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Kruis more than expected).

Fields of papers citing papers by Wolfgang Kruis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Kruis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Kruis. The network helps show where Wolfgang Kruis may publish in the future.

Co-authorship network of co-authors of Wolfgang Kruis

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Kruis. A scholar is included among the top collaborators of Wolfgang Kruis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Kruis. Wolfgang Kruis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kruis, Wolfgang, et al.. (2023). Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis. United European Gastroenterology Journal. 11(8). 775–783. 13 indexed citations
2.
3.
4.
Teich, Niels, Wolfgang Mohl, Christian Primas, et al.. (2020). Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn’s disease: results from a large case–control study. Scandinavian Journal of Gastroenterology. 55(9). 1028–1034. 4 indexed citations
5.
Schreiber, Stefan, Heinz Hartmann, Wolfgang Kruis, et al.. (2016). [Inflammatory Bowel Disease Competence Network].. PubMed. 59(4). 465–74. 2 indexed citations
6.
Kruis, Wolfgang & Gloria Nguyen. (2016). Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not?. Digestive Diseases. 34(1-2). 105–111. 33 indexed citations
7.
Rogler, Gerhard, Xavier Aldeguer, Wolfgang Kruis, et al.. (2013). Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn s and Colitis. 7(8). 670–677. 45 indexed citations
8.
Hasselblatt, Peter, Karin Potthoff, Hartmut Bertz, et al.. (2012). Remission of refractory C rohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Alimentary Pharmacology & Therapeutics. 36(8). 725–735. 45 indexed citations
9.
Kruis, Wolfgang, et al.. (2012). The effect of third-party reporting on adoption of evidence-based mesalazine regimens in ulcerative colitis: An observational study. Journal of Crohn s and Colitis. 7(4). e125–e132. 2 indexed citations
10.
Hasselblatt, Peter, Karin Potthoff, Hartmut Bertz, et al.. (2011). High-dose cyclophosphamide and autologous hematopoieitic cell transplantation for inflammatory bowel disease – a single center experience. Zeitschrift für Gastroenterologie. 49(8). 1 indexed citations
11.
Holtmeier, Wolfgang, Stefan Zeuzem, Wolfgang Kruis, et al.. (2010). Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease. Inflammatory Bowel Diseases. 17(2). 573–582. 62 indexed citations
12.
Oxelmark, Lena, Pernilla Hillerås, Axel Dignaß, et al.. (2006). Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis. Scandinavian Journal of Gastroenterology. 42(3). 406–407. 6 indexed citations
13.
Ahsen, Nicolas von, Victor W. Armstrong, Christoph Behrens, et al.. (2005). Association of Inosine Triphosphatase 94C>A and Thiopurine S-Methyltransferase Deficiency with Adverse Events and Study Drop-Outs under Azathioprine Therapy in a Prospective Crohn Disease Study. Clinical Chemistry. 51(12). 2282–2288. 75 indexed citations
14.
Kruis, Wolfgang, et al.. (2004). Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 53(11). 1617–1623. 895 indexed citations breakdown →
15.
Blum–Oehler, Gabriele, Sibylle Oswald, U. Sonnenborn, et al.. (2003). Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Research in Microbiology. 154(1). 59–66. 71 indexed citations
16.
Kruis, Wolfgang, et al.. (2000). Dose finding study of the efficacy and safety of newly developed 5-ASA containing pellets in patients with active ulcerative colitis. Gastroenterology. 118(4). A780–A780. 4 indexed citations
17.
Scheurlen, Christian, H. Allgayer, Wolfgang Kruis, Erland Erdmann, & Tilman Sauerbruch. (1993). Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. Journal of Molecular Medicine. 71(4). 286–9. 14 indexed citations
18.
Feurle, Gerhard E., et al.. (1989). Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.. Gut. 30(10). 1354–1361. 44 indexed citations
19.
Kruis, Wolfgang, Ch. Thieme, M. Weinzierl, et al.. (1984). A diagnostic score for the irritable bowel syndrome. Gastroenterology. 87(1). 1–7. 69 indexed citations
20.
Kruis, Wolfgang, et al.. (1979). [Endoscopic diagnoses in patients with positive Hemoccult-test: critical consideration and negative Hemoccult-test (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 74(44). 1641–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. D’Incà Breakdown of academic impact, for papers by Martin Hiele Breakdown of academic impact, for papers by Torsten Kucharzik Breakdown of academic impact, for papers by David S. Rampton Breakdown of academic impact, for papers by Hans Herfarth Breakdown of academic impact, for papers by Fernando Rizzello Breakdown of academic impact, for papers by Govind Makharia Breakdown of academic impact, for papers by Stig Bengmark Breakdown of academic impact, for papers by Massimo Campieri Breakdown of academic impact, for papers by Levinus A. Dieleman
Rankless by CCL
2026